Investors in Ar

The ALS Investment Fund supports and finances biotech companies that develop drugs and diagnostics for Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease. The ALS Investment Fund was initiated by Dutch ALS patients and is advised by a top-tier European VC firm, Life Sciences Partners. The ALS Investment Fund invests globally, but focuses on Europe and the US. The fund brings depth of disease-specific knowledge and a deep network in the space.

TRGC is committed to a hands-on approach with its portfolio companies, aiming to add value from day one. With over 15 years of industry experience, TRGC leverages its expertise to support promising founders who demonstrate visionary ideas and strong execution capabilities. The firm prioritizes active involvement and strategic guidance, working closely with entrepreneurs to navigate challenges, accelerate growth, and achieve impactful outcomes. TRGC's dedication to backing innovative ventures reflects its commitment to fostering long-term success and driving positive change within the industries it invests in. For more information, you can visit their website: TRGC

Based in Amsterdam, our entrepreneurial investment firm focuses exclusively on early-stage ventures within the online and mobile sectors. We are driven by a mission to identify and invest in passionate entrepreneurs who offer unique products or services with scalable potential and a recurring revenue model. Central to our investment strategy is our hatch philosophy, which emphasizes three key pillars: first, we bring clarity and focus to business planning, strategy development, and roadmap execution; second, we accelerate growth by leveraging our extensive network and industry connections to facilitate strategic partnerships and market access; and third, we catalyze the development of each venture's internal capabilities, fostering sustainable competitive advantages. Through strategic deployment of capital, hands-on mentorship, and access to our robust network, we empower entrepreneurs to realize their vision and establish leadership in the dynamic landscape of digital innovation.

BFly Ventures (formerly known as WoodWing Ventures), based in Zaandam, the Netherlands, is an early-stage venture capital company. We invest in ambitious, early-stage software companies with creative entrepreneurs, bright ideas, and promising products. Our focus is on nurturing innovation and supporting the growth of businesses that have the potential to disrupt markets and drive technological advancements. By providing both capital and strategic guidance, we help these companies navigate their early stages and accelerate their development. Our commitment is to fostering long-term success and creating value for both the entrepreneurs and our investors.

De Friesland recognizes that innovation is crucial for ensuring the accessibility and affordability of healthcare. That's why we actively invest in numerous organizations and projects dedicated to shaping a sustainable healthcare landscape. By supporting innovative initiatives, we aim to enhance the quality of care while addressing healthcare challenges effectively. Our commitment extends to fostering collaborations and partnerships that drive meaningful advancements in the sector.

RoboValley is the non-profit foundation that sustains RoboHouse, a future of work fieldlab for cognitive robotics. The RoboHouse team and its network of robotics experts and industry partners believe that we need a new research and development practice to answer one of the most current questions in cognitive robotics and society: ‘How do we make work healthy and empowering?’ We have created an industrial environment on the TU Delft Campus designed to encourage practical and inclusive collaboration, where innovative organisations, SMEs and talented individuals can develop and test their robotics applications in a variety of settings and contexts.

Capital Mills, established in 2016, bridges the gap between individual angel investors and traditional investment funds through a robust network comprising over 50 investors. Focused primarily on technology ventures, all investors at Capital Mills boast entrepreneurial backgrounds, bringing invaluable expertise and insight to the table. This network proves highly beneficial to the companies they fund, providing not just capital but also strategic guidance and operational support. Capital Mills operates with an agile investment team dedicated to day-to-day operations, ensuring efficient and effective engagement with portfolio companies. This proactive approach enhances the growth trajectory of their investments, fostering sustainable development and maximizing value creation.

RUG Holding is a venture capital firm dedicated to investing in innovative companies within the biotechnology and regulated business sectors. With a strategic focus on fostering advancements in biotech and regulated industries, RUG Holding identifies promising startups and growth-stage enterprises poised for impactful growth and development. The firm provides essential capital, strategic guidance, and operational support to empower portfolio companies in navigating complex regulatory landscapes and accelerating market adoption. By leveraging its expertise and network, RUG Holding aims to drive innovation, facilitate industry leadership, and create sustainable value for its stakeholders. Positioned at the intersection of science, technology, and regulation, RUG Holding plays a crucial role in shaping the future of biotech and regulated markets.

BrightCap Ventures is an early-stage venture capital firm investing in companies with defensible technology and significant global growth potential. Headquartered in Sofia, BrightCap leverages an extended network in Silicon Valley and Europe to assist its portfolio companies. Their strategic approach focuses on providing not only capital but also valuable connections and expertise to help startups scale and succeed internationally. BrightCap aims to identify and support innovative ventures with the potential to disrupt industries and create substantial value in the global market. Their commitment to fostering growth makes them a pivotal player in the venture capital landscape.

The ifund Foundation aims to sustain the long-term quality of life for all mankind, by stimulating the transition to a sustainable society in which renewable energy can be generated locally, organic food can be produced, clean water can be accessed, and waste is minimised or reused. On the one hand, ifund supports innovative, impact-first start-ups that develop solutions within our focus areas. This can consist of financial support such as seed capital or of organisational support theoretical research or office space. On the other hand, ifund creates awareness by providing information about the severity of the problems at hand and promoting solutions related to our focus areas.

Keadyn is a dynamic Dutch-based seed and early-stage venture investment company specializing in tech-based startups. Beyond financial backing, Keadyn offers strategic and operational involvement through its extensive network of functional experts. The Keadyn circle comprises seasoned entrepreneurs with a proven track record of success, leveraging their vast international network to support portfolio companies. With a focus on fostering innovation and growth, Keadyn plays an active role in guiding startups from inception to scaling phase. Their hands-on approach includes providing mentorship, access to resources, and facilitating strategic partnerships. By aligning with ambitious founders, Keadyn aims to drive forward-thinking solutions and contribute to the evolution of the global tech ecosystem.

Keen Venture Partners is a prominent venture capital firm based in London, specializing in growth-stage investments across technology-enabled sectors in Europe. Since its inception, Keen Venture Partners has been dedicated to supporting entrepreneurial ventures with innovative technologies and scalable business models. Focusing on areas such as enterprise software, digital media, consumer internet, and healthcare technology, the firm provides capital primarily during Series A and Series B funding rounds. Beyond financial backing, Keen Venture Partners offers strategic guidance and operational expertise to help portfolio companies navigate complexities, expand market presence, and accelerate product development. With a robust network of industry experts and advisors, Keen Venture Partners aims to foster sustainable growth and drive market disruption within the European tech ecosystem, contributing to the advancement of innovative solutions and entrepreneurial success.